These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6198202)

  • 1. Development of a new tachykinin antagonist.
    Mathison R; Stofer P; Barja F; Immer H
    Experientia; 1984 Jan; 40(1):86-8. PubMed ID: 6198202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of tachykinins with an adrenergic receptor in the rat urinary bladder.
    Mathison R; Solomos D
    Eur J Pharmacol; 1985 Mar; 109(3):327-33. PubMed ID: 2580719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the tachykinin antagonist, [D-Pro4, D-Trp7,9,10] substance P-(4-11), on tachykinin- and histamine-induced inositol phosphate generation in intestinal smooth muscle.
    Bailey SJ; Lippe IT; Holzer P
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):296-300. PubMed ID: 2438561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
    Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
    Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachykinin-like central activity of neuromedin K in mice.
    Vaught JL; Post LJ; Jacoby HI; Wright D
    Eur J Pharmacol; 1984 Aug; 103(3-4):355-7. PubMed ID: 6208040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro actions of mammalian tachykinins.
    Holzer-Petsche U; Schimek E; Amann R; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):130-5. PubMed ID: 2413373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
    Featherstone RL; Fosbraey P; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile effects of substance P and other tachykinins on the mouse isolated distal colon.
    Fontaine J; Lebrun P
    Br J Pharmacol; 1989 Mar; 96(3):583-90. PubMed ID: 2470454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.
    Johansson A; Liu L; Holmgren S; Burcher E
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):35-45. PubMed ID: 15235762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Trp7,9]-substance P as tachykinin partial agonists in the rat colon.
    Bailey SJ; Jordan CC
    Br J Pharmacol; 1984 Jun; 82(2):441-51. PubMed ID: 6203595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of potency of substance P and related peptides on [3H]-acetylcholine release, and contractile actions, in the guinea-pig ileum.
    Fosbraey P; Featherstone RL; Morton IK
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):111-5. PubMed ID: 6206402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins.
    Hua X; Lundberg JM; Theodorsson-Norheim E; Brodin E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):196-201. PubMed ID: 6084817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of tachykinin receptors examined by intracellular recording from chick sympathetic ganglia.
    Ramirez OA; Chiappinelli VA
    Brain Res; 1987 Jun; 414(2):228-38. PubMed ID: 2441802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of substance P and other tachykinins on arterial pressure in guinea-pigs.
    Hancock JC; Hoover DB
    J Auton Pharmacol; 1985 Mar; 5(1):25-30. PubMed ID: 2580843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel bioassay of physalaemin and kassinin, a tachykinin dodecapeptide from the skin of the African frog Kassina senegalensis.
    Erspamer GF; Erspamer V; Piccinelli D
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):61-5. PubMed ID: 6929037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.
    Bailey SJ; Featherstone RL; Jordan CC; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):79-85. PubMed ID: 2420403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance K: a novel mammalian tachykinin that differs from substance P in its pharmacological profile.
    Nawa H; Doteuchi M; Igano K; Inouye K; Nakanishi S
    Life Sci; 1984 Mar; 34(12):1153-60. PubMed ID: 6200746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natural tachykinins on ovine lower urinary tract smooth muscle.
    Tucci P; Bolle P; Severini C
    J Auton Pharmacol; 2001 Apr; 21(2):79-84. PubMed ID: 11679016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.